Two Sigma Securities’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-21,200
Closed -$2.8M 3777
2024
Q1
$2.8M Buy
21,200
+16,100
+316% +$2.01M 0.03% 614
2023
Q4
$621K Buy
+5,100
New +$569K 0.01% 1397
2023
Q3
Sell
-3,600
Closed -$524K 3569
2023
Q2
$524K Buy
3,600
+1,300
+57% +$177K 0.01% 1402
2023
Q1
$297K Buy
2,300
+600
+35% +$75.3K 0.01% 1716
2022
Q4
$217K Buy
+1,700
New +$197K 0.01% 1874
2022
Q3
Sell
-2,000
Closed -$210K 3195
2022
Q2
$210K Sell
2,000
-1,000
-33% -$119K 0.01% 1620
2022
Q1
$384K Buy
+3,000
New +$362K 0.01% 1210
2020
Q4
Sell
-3,605
Closed -$476K 2006
2020
Q3
$476K Sell
3,605
-17,613
-83% -$2.3M 0.01% 626
2020
Q2
$2.46M Buy
+21,218
New +$2.44M 0.06% 187
2020
Q1
Sell
-2,575
Closed -$374K 2450
2019
Q4
$374K Sell
2,575
-3,605
-58% -$498K ﹤0.01% 1643
2019
Q3
$824K Buy
6,180
+2,884
+88% +$373K 0.01% 967
2019
Q2
$377K Buy
+3,296
New +$386K ﹤0.01% 1316
2018
Q3
Sell
-7,519
Closed -$814K 3099
2018
Q2
$814K Buy
7,519
+5,150
+217% +$561K ﹤0.01% 1467
2018
Q1
$251K Buy
2,369
+412
+21% +$47.8K ﹤0.01% 2126
2017
Q4
$229K Buy
+1,957
New +$221K 0.01% 1205

Other funds holding ZBH

Two Sigma Securities's ZBH Position: Q1 2025 in Review

Two Sigma Securities sold out of Zimmer Biomet (ZBH) in Q1 2025, closing a stake of 2,811 shares — an estimated $297K sold.

Two Sigma Securities first reported a position in ZBH in Q3 2016 and held it in 14 quarters. The position peaked at $1.72M in Q3 2018. 1,000 funds tracked by Wall St. Rank hold ZBH as of Q1 2025.

  • Two Sigma Securities reported no remaining Zimmer Biomet position as of Q1 2025 after selling out during the quarter.
  • Two Sigma Securities sold 2,811 Zimmer Biomet shares in Q1 2025, an estimated $297K.
  • Two Sigma Securities first reported a position in Zimmer Biomet in Q3 2016 and held it in 14 quarters.
  • Two Sigma Securities's Zimmer Biomet position peaked at $1.72M in Q3 2018.
  • 1,000 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2025.

Based on Two Sigma Securities's 13F filing for Q1 2025, filed 15 May 2025.